Literature DB >> 20597666

Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

Brad Spellberg, George Talbot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20597666      PMCID： PMC2947853          DOI： 10.1086/653065

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  88 in total

1.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

2.  The long range effect of antibacterial therapy on pneumonia, empyema, bronchiectasis and pulmonary abscess; an analysis of incidence and mortality in 74,489 admissions to a Children's Hospital in twenty years.

Authors:  K E KASSOWITZ; G H MUSCATO
Journal:  Dis Chest       Date:  1952-02

3.  Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  A S Levin; A A Barone; J Penço; M V Santos; I S Marinho; E A Arruda; E I Manrique; S F Costa
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

Review 4.  Hospital-acquired pneumonia: epidemiology, etiology, and treatment.

Authors:  R McEachern; G D Campbell
Journal:  Infect Dis Clin North Am       Date:  1998-09       Impact factor: 5.982

5.  Diagnosis and treatment of ventilator-associated pneumonia--impact on survival. A decision analysis.

Authors:  T R Sterling; E J Ho; W T Brehm; M B Kirkpatrick
Journal:  Chest       Date:  1996-10       Impact factor: 9.410

6.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.

Authors:  M J Richards; J R Edwards; D H Culver; R P Gaynes
Journal:  Crit Care Med       Date:  1999-05       Impact factor: 7.598

7.  Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study.

Authors:  J M Sanchez-Nieto; A Torres; F Garcia-Cordoba; M El-Ebiary; A Carrillo; J Ruiz; M L Nuñez; M Niederman
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

8.  The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

Authors:  M H Kollef; S Ward
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

9.  The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia.

Authors:  M H Kollef; K R Bock; R D Richards; M L Hearns
Journal:  Ann Intern Med       Date:  1995-05-15       Impact factor: 25.391

10.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272
View more
  21 in total

1.  White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens.

Authors: 
Journal:  Clin Infect Dis       Date:  2012-08-13       Impact factor: 9.079

2.  Combating antimicrobial resistance: policy recommendations to save lives.

Authors:  Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

3.  Quantitative cultures of bronchoscopically obtained specimens should be performed for optimal management of ventilator-associated pneumonia.

Authors:  Vickie Baselski; J Stacey Klutts; Vickie Baselski; J Stacey Klutts
Journal:  J Clin Microbiol       Date:  2013-01-02       Impact factor: 5.948

4.  10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; Daniel K Benjamin; John Bradley; Robert J Guidos; Ronald N Jones; Barbara E Murray; Robert A Bonomo; David Gilbert
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079

5.  Influence of bronchoscopy on the diagnosis of and outcomes from ventilator-associated pneumonia.

Authors:  Christopher A Guidry; Michael U Mallicote; Robin T Petroze; Tjasa Hranjec; Laura H Rosenberger; Stephen W Davies; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2014-05-19       Impact factor: 2.150

6.  Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.

Authors:  Vance G Fowler; Anita F Das; Joy Lipka-Diamond; Raymond Schuch; Roger Pomerantz; Luis Jáuregui-Peredo; Adam Bressler; David Evans; Gregory J Moran; Mark E Rupp; Robert Wise; G Ralph Corey; Marcus Zervos; Pamela S Douglas; Cara Cassino
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

7.  Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia.

Authors:  Brad Spellberg; Roger J Lewis; Helen W Boucher; Eric P Brass
Journal:  Clin Investig (Lond)       Date:  2011-01-01

8.  Characterization of the biological anti-staphylococcal functionality of hUK-66 IgG1, a humanized monoclonal antibody as substantial component for an immunotherapeutic approach.

Authors:  Babett Oesterreich; Birgit Lorenz; Tim Schmitter; Roland Kontermann; Michael Zenn; Bastian Zimmermann; Markus Haake; Udo Lorenz; Knut Ohlsen
Journal:  Hum Vaccin Immunother       Date:  2014-02-04       Impact factor: 3.452

9.  The deadly impact of extreme drug resistance in Acinetobacter baumannii.

Authors:  Brad Spellberg; Robert A Bonomo
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

10.  Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia.

Authors:  Travis B Nielsen; Jun Yan; Brian Luna; Brad Spellberg
Journal:  J Vis Exp       Date:  2018-06-28       Impact factor: 1.355
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.